← All Sponsors
SPONSOR

COUR Pharmaceutical Development Company, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Myasthenia GravisGeneralized MyastheniaAChR Myasthenia GravisMuSK MG
NCT06106672 Phase 1, Phase 2
Recruiting

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Myasthenia Gravis
United States View Trial →